//Your Connection to the Life Sciences Industry
Connect to IBC:LinkedIn iconTwitter iconFacebook iconBlog iconRSS icon
EmailPrint

TIDES: Oligonucleotide and Peptide Therapeutics from Research through Commercialization

CSS

Agenda CSS

The #1 Industry Forum for CMC, Clinical and Discovery Scientists to Accelerate Product Development

May 03-06, 2015
Town and Country Resort
San Diego, CA

Agenda Summary

Agenda Summary

Agenda-at-a-Glance

 

Workshop #1:
Manufacturing and Quality Considerations to Support Late Stage Development of Oligonucleotides

Workshop #2:
Anatomy of Peptide and Oligonucleotide INDs: Overcome Early Development Challenges and Find Solutions

Workshop #3:
Emerging Peptide Structures and Challenges for CMC Development

Workshop #4:
Process Qualification, Quality-by-Design (QbD) and Continuous Process Verification Strategies for Oligonucleotides and Peptides

AM

Keynote Presentations

PM

Plenary Session

 

Casino Night Networking Reception in Poster and Exhibit Hall Sponsored by Lonza

 

Oligonucleotide Chemistry Manufacturing and Controls

Peptide Chemistry Manufacturing and Controls

Peptide Discovery, Preclinical and Clinical

Oligonucleotide Discovery, Preclinical and Clinical

AM

Advances in Delivery

New Frontiers

New Developments in Oligonucleotide Manufacturing

Conjugation Strategies for Peptide Half-Life Extension

Mechanisms of Delivery

 

Networking Luncheon in Poster and Exhibit Hall

PM

New Developments in Oligonucleotide Manufacturing

Non-Injectable and Non-Invasive Methods for Peptide Drug Delivery

Peptide Discovery

Discovery and Preclinical Development of Oligonucleotides

Regulatory Perspectives

Advances in Manufacturing of Peptides

Strategy Discussion Forum

 

Networking Reception in Poster and Exhibit Hall

 

Oligonucleotide Chemistry Manufacturing and Controls

Peptide Chemistry Manufacturing and Controls

Peptide Discovery, Preclinical and Clinical

Oligonucleotide Discovery, Preclinical and Clinical

AM

Oligonucleotide CMC Challenges and Case Studies

Novel Peptide Chemistry

New Platforms for Lead Generation of Macrocyclic Peptides

Clinical Updates on Oligonucleotides

Peptide CMC Challenges & Case Studies

Control Strategies Strategy Discussion Forum

Analytical and Formulation Strategies to Improve Peptide Properties

Peptide Transport and Permeability

 

Networking Luncheon in Poster and Exhibit Hall

PM

Drug Product Strategies and Solutions for Oligonucleotides and Peptides

New Peptide Frontiers and Novel Indications

Aptamer Development

Case Studies

Immunomodulatory Oligonucleotides

Alternately, click on the track titles below to view the full agenda for each track.

Sunday Workhops

Sunday, May 3, 2015

  • Workshop #1: Manufacturing and Quality Considerations to Support Late Stage Development of Oligonucleotides
  • Workshop #2: Anatomy of Peptide and Oligonucleotide INDs: Overcome Early Development Challenges and Find Solutions
  • Workshop #3: Emerging Peptide Structures and Challenges for CMC Development
  • Workshop #4: Process Qualification, Quality-by-Design (QbD) and Continuous Process Verification Strategies for Oligonucleotides and Peptides

Monday Keynotes & Plenary Sessions

Monday, May 4, 2015

Tuesday-Wednesday Tracks

Tuesday, May 5, 2015 and Wednesday, May 6, 2015

skyline